newsfilter
← Latest News
GlobeNewswire·

First Wave BioPharma Regains Compliance With Nasdaq's Minimum Bid Price Requirement

BOCA RATON, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of